欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NO/H/0266/001
药品名称
Ventizolve
活性成分
naloxone hydrochloride 1.0 mg
剂型
Nasal spray, solution
上市许可持有人
Farma Industri AS
参考成员国 - 产品名称
Norway (NO)
Ventizolve
互认成员国 - 产品名称
Germany (DE)
VentiZolve
Denmark (DK)
Belgium (BE)
Ventizolve 1,26 mg, solution pour pulvérisation nasale en récipient unidose
Netherlands (NL)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Italy (IT)
Sweden (SE)
Finland (FI)
Estonia (EE)
VENTIZOLVE
许可日期
2018/06/14
最近更新日期
2024/03/22
药物ATC编码
V03AB15 naloxone
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PAR Summary
|
Ventizolve - Summary Public Assessment Report
Date of last change:2020/02/26
PAR
|
Ventizolve -Public Assessment Report - Scientific discussion
Date of last change:2020/02/26
Final Labelling
|
Ventizolve - common LAB
Date of last change:2020/02/26
Final PL
|
Ventizolve - common PIL
Date of last change:2020/02/26
Final SPC
|
Ventizolve - common SPC
Date of last change:2020/02/26
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase